Noncalcemic actions of vitamin D receptor ligands - PubMed (original) (raw)
Review
doi: 10.1210/er.2004-0002. Epub 2005 Mar 29.
Affiliations
- PMID: 15798098
- DOI: 10.1210/er.2004-0002
Review
Noncalcemic actions of vitamin D receptor ligands
Sunil Nagpal et al. Endocr Rev. 2005 Aug.
Abstract
1alpha,25-Dihydroxyvitamin D(3) [1,25-(OH)(2)D(3)], the active metabolite of vitamin D(3), is known for the maintenance of mineral homeostasis and normal skeletal architecture. However, apart from these traditional calcium-related actions, 1,25-(OH)(2)D(3) and its synthetic analogs are being increasingly recognized for their potent antiproliferative, prodifferentiative, and immunomodulatory activities. These actions of 1,25-(OH)(2)D(3) are mediated through vitamin D receptor (VDR), which belongs to the superfamily of steroid/thyroid hormone nuclear receptors. Physiological and pharmacological actions of 1,25-(OH)(2)D(3) in various systems, along with the detection of VDR in target cells, have indicated potential therapeutic applications of VDR ligands in inflammation (rheumatoid arthritis, psoriatic arthritis), dermatological indications (psoriasis, actinic keratosis, seborrheic dermatitis, photoaging), osteoporosis (postmenopausal and steroid-induced osteoporosis), cancers (prostate, colon, breast, myelodysplasia, leukemia, head and neck squamous cell carcinoma, and basal cell carcinoma), secondary hyperparathyroidism, and autoimmune diseases (systemic lupus erythematosus, type I diabetes, multiple sclerosis, and organ transplantation). As a result, VDR ligands have been developed for the treatment of psoriasis, osteoporosis, and secondary hyperparathyroidism. Furthermore, encouraging results have been obtained with VDR ligands in clinical trials of prostate cancer and hepatocellular carcinoma. This review deals with the molecular aspects of noncalcemic actions of vitamin D analogs that account for the efficacy of VDR ligands in the above-mentioned indications.
Similar articles
- Vitamin D receptor as a drug discovery target.
Pinette KV, Yee YK, Amegadzie BY, Nagpal S. Pinette KV, et al. Mini Rev Med Chem. 2003 May;3(3):193-204. doi: 10.2174/1389557033488204. Mini Rev Med Chem. 2003. PMID: 12570835 Review. - Vitamin D analogs: mechanism of action and therapeutic applications.
Nagpal S, Lu J, Boehm MF. Nagpal S, et al. Curr Med Chem. 2001 Nov;8(13):1661-79. doi: 10.2174/0929867013371950. Curr Med Chem. 2001. PMID: 11562285 Review. - Vitamin D receptor ligands for osteoporosis.
Cheskis BJ, Freedman LP, Nagpal S. Cheskis BJ, et al. Curr Opin Investig Drugs. 2006 Oct;7(10):906-11. Curr Opin Investig Drugs. 2006. PMID: 17086935 Review. - The importance of stereochemistry on the actions of vitamin D.
Chiellini G, DeLuca HF. Chiellini G, et al. Curr Top Med Chem. 2011;11(7):840-59. doi: 10.2174/156802611795165016. Curr Top Med Chem. 2011. PMID: 21291397 Review. - Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
Choi M, Makishima M. Choi M, et al. Expert Opin Ther Pat. 2009 May;19(5):593-606. doi: 10.1517/13543770902877717. Expert Opin Ther Pat. 2009. PMID: 19441936 Review.
Cited by
- Vitamin D deficiency as a potential risk factor for accelerated aging, impaired hippocampal neurogenesis and cognitive decline: a role for Wnt/β-catenin signaling.
Gómez-Oliva R, Geribaldi-Doldán N, Domínguez-García S, Carrascal L, Verástegui C, Nunez-Abades P, Castro C. Gómez-Oliva R, et al. Aging (Albany NY). 2020 Jun 17;12(13):13824-13844. doi: 10.18632/aging.103510. Epub 2020 Jun 17. Aging (Albany NY). 2020. PMID: 32554862 Free PMC article. Review. - Inflammation regulates fibroblast growth factor 23 production.
Francis C, David V. Francis C, et al. Curr Opin Nephrol Hypertens. 2016 Jul;25(4):325-32. doi: 10.1097/MNH.0000000000000232. Curr Opin Nephrol Hypertens. 2016. PMID: 27191351 Free PMC article. Review. - Correlation between secosteroid-induced vitamin D receptor activity in melanoma cells and computer-modeled receptor binding strength.
Kim TK, Wang J, Janjetovic Z, Chen J, Tuckey RC, Nguyen MN, Tang EK, Miller D, Li W, Slominski AT. Kim TK, et al. Mol Cell Endocrinol. 2012 Sep 25;361(1-2):143-52. doi: 10.1016/j.mce.2012.04.001. Epub 2012 Apr 21. Mol Cell Endocrinol. 2012. PMID: 22546549 Free PMC article. - Vitamin D deficiency is highly prevalent in malnourished inpatients and associated with higher mortality: A prospective cohort study.
Merker M, Amsler A, Pereira R, Bolliger R, Tribolet P, Braun N, Hoess C, Pavlicek V, Bilz S, Sigrist S, Brändle M, Henzen C, Thomann R, Rutishauser J, Aujesky D, Rodondi N, Donzé J, Stanga Z, Mueller B, Schuetz P. Merker M, et al. Medicine (Baltimore). 2019 Nov;98(48):e18113. doi: 10.1097/MD.0000000000018113. Medicine (Baltimore). 2019. PMID: 31770235 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials